Tesamorelin
A GHRH analogue that targets deep visceral fat.
iThe essentials in 10 seconds
- GHRH analogue — stimulates natural growth hormone
- Mainly targets visceral fat (deep abdominal fat)
- The only treatment in this family approved for its primary indication
- Daily subcutaneous injection, under medical supervision
IWhat is Tesamorelin?
Tesamorelin is a GHRH analogue that stimulates growth hormone secretion. Its benefit: it specifically reduces visceral fat — the deep fat around the organs, linked to cardiometabolic risk — where diet has less effect. It is approved for HIV-associated lipodystrophy and studied in steatosis and metabolic syndrome.
Highly regulated medication, requiring strict prescription and monitoring (IGF-1, blood glucose). Apart from its primary indication, evidence remains limited.
IIThe benefits
Reduces deep abdominal fat surrounding the organs, linked to cardiometabolic risk.
Decreases waist circumference, a simple marker of metabolic risk.
Increases energy expenditure and fat oxidation.
Overall goal: triglycerides, inflammation, insulin sensitivity.
Area of interest in non-alcoholic fatty liver disease (studies).
Unlike many treatments, preserves lean mass.
IIIRecommendations & how to use
Route: subcutaneous injection (abdomen) · Frequency: daily, at a regular time · Storage: refrigerated (2–8 °C).
Treatment under medical supervision (IGF-1, blood glucose, tolerability).
| Dosage | Euro | Dollar | Dirham |
|---|---|---|---|
| 10 mg | 124 € | 135 $ | 1350 DH |
Indicative exchange rates — final price confirmed during consultation.
IVThe two protocols
Goal: reduce visceral fat and waist circumference.
Monitoring: waist circumference, IGF-1, tolerability (injection site pain, blood glucose).
Goal: improve body composition and metabolic profile.
Combine with: physical activity and dietary habits; the peptide is an adjunct.
VProtocol rules
- Controlled diet (refined sugars, alcohol)
- Regular physical activity
- Record waist circumference and how you feel
- Comply with laboratory monitoring
- Store vials in the refrigerator
- Never self-medicate: prescription-only treatment
- Do not exceed the dose
- Vary injection sites (local pain)
- Do not continue without reassessment
- Pregnancy, breastfeeding, active tumor: contraindication
VIYour journey in 3 steps
Metabolic evaluation, contraindications, workup (IGF-1, blood glucose), protocol provided.
1 injection/day, monitoring of waist circumference and tolerability.
Laboratory and metabolic workup, decision on next steps.